Johnson & Johnson declares $1.34 dividend for Q3 2026
Johnson & Johnson declared a $1.34 per share dividend for Q3 2026, payable on September 8, 2026, to shareholders of record on August 25, 2026.
*this image is generated using AI for illustrative purposes only.
Johnson & Johnson has declared a cash dividend of $1.34 per share on its common stock for the third quarter of 2026. The dividend is payable on September 8, 2026 to shareholders of record at the close of business on August 25, 2026. The ex-dividend date is August 25, 2026.
Dividend Details
The Board of Directors of Johnson & Johnson approved the dividend, maintaining the company's commitment to returning value to shareholders. The payment will be made to investors who hold the stock at the close of business on the record date.
| Key Date | Date |
|---|---|
| Record Date | August 25, 2026 |
| Ex-Dividend Date | August 25, 2026 |
| Payment Date | September 8, 2026 |
About Johnson & Johnson
Johnson & Johnson operates in Innovative Medicine and MedTech sectors. The company focuses on healthcare innovation to prevent, treat, and cure complex diseases.
How will J&J's Innovative Medicine and MedTech performance impact future dividend sustainability?
Could this dividend signal a shift in J&J's capital allocation strategy?
How might J&J's dividend compare to peers in the healthcare sector by late 2026?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
